JD Supra: Mergers

JUNE 4, 2024

Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission's (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare "roll-up" strategy of its anesthesia practice management portfolio company. The case, Federal Trade Commission v.

Private Equity 185

Private Equity Healthcare Equities Portfolio 185

JD Supra: Mergers

OCTOBER 11, 2024

State legislatures across the country are beginning to consider and debate the pros and cons of passing laws aimed at regulating private equity’s role in the healthcare industry. Originally published in The Journal Record - October 10, 2024. By: McAfee & Taft

Private Equity 175

Private Equity Healthcare Equities 175

JD Supra: Mergers

AUGUST 15, 2024

healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. private equity investors has reached an all-time high, and with capital on the sideline ready to deploy, pressure to get deals done is on the rise. Although the U.S. Dry powder held by U.S.

Private Equity 175

Private Equity Healthcare Equities M&A 175

JD Supra: Mergers

AUGUST 1, 2024

Over the last decade, private equity firms have acquired healthcare companies, hospitals, and clinics at an increasing rate. In fact, in those ten years, private equity firms have spent roughly $1 trillion on an estimated 8,000 healthcare deals. This trend is only expected to increase through 2024.

Private Equity 157

Private Equity Healthcare Equities Portfolio 157

JD Supra: Mergers

MAY 22, 2024

McGuireWoods recently held its 20th Annual Healthcare Private Equity and Finance Conference (HCPE Conference) in Chicago. The conference drew more than 1,000 professionals from private equity funds, senior and mezzanine lenders, and investment banks, as well as C-level executives, consultants and principals in the healthcare industry.

Private Equity 163

Private Equity Healthcare Finance Finance 163

JD Supra: Mergers

JANUARY 10, 2025

As some packed the skis and headed to their favorite slopes this winter season, it is hard not to see the analogies to the healthcare private equity (PE) transaction market as we ring in the New Year. Much like the Northern Rockies, there should be plenty of dry powder to support a robust dealmaking environment in 2025.

Private Equity 163

Private Equity Healthcare Equities IT 163

JD Supra: Mergers

MARCH 15, 2024

From the West Coast Healthcare Desk is an ongoing series of Holland & Knight Healthcare Blog articles and alerts focused on healthcare industry developments and points of interest in the West Coast healthcare marketplace.

Healthcare 175

Healthcare Private Equity Equities 175

JD Supra: Mergers

MARCH 12, 2024

Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. By: Mayer Brown

Private Equity 180

Private Equity Healthcare Equities Acquisitions 180

JD Supra: Mergers

FEBRUARY 26, 2025

Private equity (PE) investment in the U.S. healthcare sector faces a complex and evolving regulatory and legislative landscape. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns about market consolidation, quality of care, corporate profiteering and lack of financial transparency.

Private Equity 185

Private Equity Healthcare Equities Investment 185

JD Supra: Mergers

OCTOBER 1, 2024

Gavin Newsom vetoed a controversial bill that would have restricted private equity and hedge fund healthcare transactions in the state. On Saturday, September 28, California Gov. By: Fenwick & West LLP

Private Equity 163

Private Equity Healthcare Equities Funds 163

JD Supra: Mergers

JULY 25, 2024

2871, An Act Enhancing the Health Care Market Review Process (the Bill), to increase oversight of healthcare transactions involving private equity firms, real estate investment trusts, and management services organizations (MSOs). On July 18, 2024, the Massachusetts Senate passed S. By: Sheppard Mullin Richter & Hampton LLP

Private Equity 169

Private Equity Healthcare Equities Management 169

JD Supra: Mergers

AUGUST 13, 2024

A recent wave of state legislation is changing the course of healthcare transactions, and organizations (particularly private equity-backed organizations) that engage in mergers and acquisitions in the healthcare industry should prepare for increased scrutiny. By: BakerHostetler

Private Equity 169

Private Equity Healthcare Equities Mergers and Acquisitions 169

JD Supra: Mergers

JANUARY 14, 2025

Among various other healthcare market oversight enhancements, the Act expands the authority of the Massachusetts Attorney General, Center for Health Information and Analysis (CHIA), and Health Policy Commission (HPC) to review and gather data regarding private equity investment into healthcare providers and healthcare management companies.

Private Equity 157

Private Equity Healthcare Equities Management 157

JD Supra: Mergers

AUGUST 5, 2024

The Massachusetts legislative session for 2024 has come to a close without the passage of a bill that would have targeted private equity in healthcare.

Private Equity 169

Private Equity Healthcare Equities Funds 169

JD Supra: Mergers

OCTOBER 1, 2024

The Bill, if enacted, would have imposed new notice and consent requirements for private equity investors involved in healthcare transactions. On September 28, 2024, California Governor Gavin Newsom vetoed California Assembly Bill 3129 (the Bill). By: Robinson+Cole Health Law Diagnosis

Private Equity 163

Private Equity Healthcare Equities Investors 163

JD Supra: Mergers

MARCH 25, 2025

AIM Equity Partners has made a majority-control growth investment in AMOpportunities (AMO), according to a news release. By: McGuireWoods LLP

Equities 150

Equities Private Equity Healthcare Investment 150

JD Supra: Mergers

JUNE 13, 2024

By: Holland & Knight LLP

Private Equity 163

Private Equity Healthcare Equities Funds 163

JD Supra: Mergers

JANUARY 14, 2025

The bill seeks to strengthen oversight of private equity investment within Massachusetts healthcare sector and enforce stricter penalties for noncompliance with reporting requirements and the state False Claims Act (FCA). 5159), and Governor Maura Healey signed it on January 8, 2025. By: McDermott Will & Emery

Private Equity 157

Private Equity Healthcare Equities Investment 157

JD Supra: Mergers

JUNE 12, 2024

Department of Health and Human Services’ (together the “Agencies”) request for information regarding consolidation in healthcare by private equity. Department of Justice, and the U.S. By: Sheppard Mullin Richter & Hampton LLP

Private Equity 169

Private Equity Healthcare Equities Trading 169

JD Supra: Mergers

MARCH 12, 2024

On March 5, the FTC convened a workshop with regulators, academics and stakeholders to discuss the impact of private equity in the healthcare market. The workshop reflects the FTC and DOJ Antitrust Division’s recent focus on private equity and serial roll-up transactions more broadly as targets for antitrust enforcement.

Private Equity 169

Private Equity Healthcare Equities Acquisitions 169

JD Supra: Mergers

JULY 17, 2024

Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing forward—especially private equity (PE) investors who need to deploy their “dry powder.”.

Healthcare 190

Healthcare Private Equity Equities Investors 190

JD Supra: Mergers

SEPTEMBER 5, 2024

AB 3129 would establish a mandatory approval process for a broad range of healthcare-related transactions involving private equity funds and hedge funds, giving the California Attorney General (“CA AG”) broad authority to block or impose restrictions on transactions to protect public interest.

Private Equity 175

Private Equity Healthcare Funds Equities 175

JD Supra: Mergers

MAY 21, 2024

Earlier this year, Indiana joined a growing number of states by enacting a new notification requirement for certain healthcare transactions.

Healthcare 190

Healthcare Private Equity Equities Investors 190

JD Supra: Mergers

MARCH 8, 2024

WindRose Health Investors has announced its acquisition of CardioOne. CardioOne, founded in 2023 and based in Houston, is a management services partner and technology platform designed for independent cardiology practices. By: McGuireWoods LLP

Private Equity 267

Private Equity Healthcare Equities Investors 267

JD Supra: Mergers

SEPTEMBER 23, 2024

On August 31, the last day of its 2024 Legislative Session, the California Legislature approved Assembly Bill 3129 (Wood), which provides for notification to and review by the Attorney General of health care transactions involving private equity groups and hedge funds. Governor Newsom is expected to sign the legislation in September.

Private Equity 169

Private Equity Equities Healthcare Funds 169

JD Supra: Mergers

JUNE 3, 2024

California’s AB 3219, which would require private equity firms and hedge funds to obtain prior approval to consummate certain healthcare-related transactions, is now one step closer to becoming law following the State Assembly’s May 22, 2024 passage of the pending legislation.

Private Equity 169

Private Equity Healthcare Equities Funds 169

JD Supra: Mergers

MAY 9, 2024

Knox Lane has announced the acquisition of All Star Healthcare Solutions. By: McGuireWoods LLP

Healthcare 150

Healthcare Private Equity Hospitality Equities 150

JD Supra: Mergers

JANUARY 24, 2025

The Act increases regulatory reporting obligations and oversight of healthcare transactions involving private equity sponsors, healthcare real estate investment trusts (REITs) and management services organizations (MSOs). Maura Healy signed An Act Enhancing the Market Review Process (the Act). By: McGuireWoods LLP

Healthcare 157

Healthcare Private Equity Investors Equities 157

JD Supra: Mergers

JULY 2, 2024

Triton Pacific Healthcare Partners has announced the closing of its sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners. BioMatrix, founded in 2001 and based in Plantation, Florida, is a provider of specialty infusion services in the United States. By: McGuireWoods LLP

Healthcare 150

Healthcare Private Equity Equities Sale 150

JD Supra: Mergers

JANUARY 16, 2025

Machinify, founded in 2016 and based in Palo Alto, California, is a provider of artificial intelligence (AI)-powered software focused on healthcare claims and payments. New Mountain Capital has announced it will acquire Machinify. By: McGuireWoods LLP

Healthcare 175

Healthcare Private Equity Equities Capital 175

JD Supra: Mergers

MARCH 11, 2025

WBA (NASDAQ: WBA), based in Deerfield, Illinois, is an integrated healthcare, pharmacy and retail company. Sycamore Partners will acquire Walgreens Boots Alliance (WBA), according to a news release. By: McGuireWoods LLP

Healthcare 150

Healthcare Private Equity Equities Retail 150

JD Supra: Mergers

MARCH 29, 2024

On February 22, 2024, the Minnesota legislature introduced a bill (SF-4392 and companion bill HR-4206) which seeks to curb the control and acquisition over certain healthcare providers by private equity companies and real estate investment trusts (REITs). By: Lathrop GPM

Healthcare 198

Healthcare Investment Private Equity Equities 198

JD Supra: Mergers

JANUARY 15, 2025

5159), An Act Enhancing the Market Review Process (the Act), which, among other things, broadens the scope of the states existing healthcare transaction notification and review regime. On January 8, 2025, Massachusetts Governor Maura Healey signed House Bill 5159 (H.5159), By: Goodwin

Healthcare 163

Healthcare Private Equity Equities Investment 163

JD Supra: Mergers

SEPTEMBER 17, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Healthcare 180

Healthcare Private Equity Equities Investment 180

JD Supra: Mergers

DECEMBER 29, 2023

13, 2023, the White House announced new efforts to lower healthcare and prescription drug costs, issuing a detailed Fact Sheet. Two of the initiatives focus on private equity investments in healthcare. White House and Agency Initiatives - On Dec. By: McGuireWoods LLP

Private Equity 163

Private Equity Healthcare Equities Investment 163

JD Supra: Mergers

AUGUST 15, 2024

California’s Senate Appropriations Committee will hold a hearing on California’s private equity bill, AB 3129, on August 15, 2024. This proposed legislation would expand existing California Attorney General authority to include review and approval authority over most healthcare private equity transactions. By: BakerHostetler

Private Equity 180

Private Equity Equities Healthcare 180

JD Supra: Mergers

JANUARY 17, 2025

Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. Long-term capital gains tax rates will likely remain unchanged, or possibly drop. By: DLA Piper

Healthcare 175

Healthcare Private Equity Portfolio M&A 175